Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02386202 · ClinicalTrials.gov registry record
ARC in Hemorrhagic Stroke
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 80
- Enrollment target
NCT02386202: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT02386202 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02386202 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
To determine the incidence and predictors of augmented renal clearance (ARC) in patients with hemorrhagic stroke.
Primary Outcome
Daily 8-hour urine collections will be performed to directly measure creatinine clearance up to ICU discharge
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-08 |
What the finished NCT02386202 record still lists
NCT02386202 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT02386202 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02386202 about?
NCT02386202 is a clinical study titled "ARC in Hemorrhagic Stroke". To determine the incidence and predictors of augmented renal clearance (ARC) in patients with hemorrhagic stroke.
What is the current status of trial NCT02386202?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2015-01. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02386202?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT02386202?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia